The efficacy and safety of furazolidone-bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotic supplementation

AIM: In this clinical trial we use furazolidone-bismuth quadruple therapy with or without probiotics for H.pylori eradication. BACKGROUND: Increasing rates of eradication failure in H.pylori infection mainly due to antibiotic resistance has led to search for alternative regimens such as using novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Noorbakhsh, Nafeh, Nikpour, Shahriar, Salehi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275735/
https://www.ncbi.nlm.nih.gov/pubmed/35845306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275735/
https://www.ncbi.nlm.nih.gov/pubmed/35845306

Ejemplares similares